Abstract
A suspension of 45%, 12%, or 3% hexachlorophene (HCP) was introduced into the vagina of pregnant rats on days 7 through 10 of gestation. The highest concentration produced a significant number of malformed offspring, 12% HCP was slightly teratogenic, but 3% had no effect. Pregnant animals from the two highest dosage groups developed moderate to severe toxicity during treatment. Uptake of HCP labeled with radioactive carbon (14C) was significant after vaginal or oral treatment and resulted in plasma concentrations six to ten times higher than did dermal application of the same dose. Concentrations of HCP were highest in vagina and liver after vaginal treatment, but extremely low in maternal brain and embryos, suggesting a transport barrier against HCP to these tissues. One third of the administered radioactivity was excreted in feces and 3% in urine within six days after a single vaginal treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
